 UPPSALA, Sweden, Aug. 31, 2021 GLOBE NEWSWIRE -- CellCarta and Olink Proteomics AB announced today a strategic collaboration to offer Olink Target 96 Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies. 